
Oramed Pharmaceuticals Inc.
ORMP
ORMP: Oramed Pharmaceuticals Inc is a pharmaceutical company which is engaged in the research and development of pharmaceutical solutions, including an oral insulin capsule to be used for the treatment of individuals with diabetes, and the use of orally ingestible capsules or pills for delivery of other polypeptides. The ORMD-0801 is a proprietary product which is an orally ingestible insulin capsule for the treatment of diabetes. Its other product includes Oral Glucagon-like peptide-1 which is an incretin hormone, a type of gastrointestinal hormone that stimulates the secretion of insulin from the pancreas.
moreShow ORMP Financials
Recent trades of ORMP by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by ORMP's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Followers on ORMP's company Twitter account
Number of mentions of ORMP in WallStreetBets Daily Discussion
Recent insights relating to ORMP
Recent picks made for ORMP stock on CNBC
ETFs with the largest estimated holdings in ORMP
Flights by private jets registered to ORMP